Holen Sie sich die Stockscreener-App
4.59
10.87%
-0.56
Handel nachbörslich:
4.56
-0.03
-0.65%
Schlusskurs vom Vortag:
$5.15
Offen:
$5.1
24-Stunden-Volumen:
53,777
Relative Volume:
0.32
Marktkapitalisierung:
$7.15M
Einnahmen:
$8.62M
Nettoeinkommen (Verlust:
$-6.15M
KGV:
-0.4161
EPS:
-11.03
Netto-Cashflow:
$-5.32M
1W Leistung:
-12.07%
1M Leistung:
+0.41%
6M Leistung:
+48.54%
1J Leistung:
-20.86%
1-Tages-Spanne:
$4.5001
$5.15
1-Wochen-Bereich:
$4.5001
$5.23
52-Wochen-Spanne:
$1.94
$9.88
Evoke Pharma Inc Stock (EVOK) Company Profile
Firmenname
Evoke Pharma Inc
Sektor
Telefon
858-345-1494
Adresse
420 STEVENS AVENUE, SOLANA BEACH, CA
Vergleichen Sie EVOK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
4.59 | 8.03M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Fortgesetzt | FBR & Co. | Buy |
| 2017-03-16 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-01-30 | Hochstufung | Laidlaw | Neutral → Buy |
| 2017-01-05 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Bestätigt | Rodman & Renshaw | Neutral |
| 2016-07-19 | Bestätigt | FBR Capital | Outperform |
| 2016-07-19 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-07-18 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Eingeleitet | Northland Capital | Outperform |
| 2016-03-14 | Bestätigt | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Fortgesetzt | FBR Capital | Outperform |
| 2014-12-03 | Bestätigt | MLV & Co | Buy |
| 2014-11-07 | Eingeleitet | MLV & Co | Buy |
| 2014-04-22 | Eingeleitet | Laidlaw | Buy |
| 2013-11-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
Evoke Pharma Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Using Bollinger Bands to evaluate Evoke Pharma Inc.Portfolio Value Summary & Stepwise Swing Trade Plans - newser.com
Top chart patterns to watch in Evoke Pharma Inc.2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Will Evoke Pharma Inc. stock continue dividend increasesJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
How to read the order book for Evoke Pharma Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Using economic indicators to assess Evoke Pharma Inc. potentialMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Identifying reversal signals in Evoke Pharma Inc.July 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
How currency fluctuations impact Evoke Pharma Inc. stockWeekly Trend Summary & Expert Verified Stock Movement Alerts - newser.com
Price action breakdown for Evoke Pharma Inc.Fed Meeting & Fast Gain Stock Tips - newser.com
Quantitative breakdown of Evoke Pharma Inc. recent moveWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Why Evoke Pharma Inc. stock is a value investor pickJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Will Evoke Pharma Inc. rebound enough to break evenJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
How sustainable is Evoke Pharma Inc. stock dividend payoutJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
Evaluating Evoke Pharma Inc. with trendline analysisJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Key metrics from Evoke Pharma Inc.’s quarterly dataDay Trade & Free Community Consensus Stock Picks - newser.com
Will Evoke Pharma Inc. stock go up soonJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stock2025 Big Picture & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Evoke Pharma Inc.2025 Performance Recap & Fast Entry High Yield Tips - newser.com
How Evoke Pharma Inc. stock responds to policy changesQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Analyzing Evoke Pharma Inc. with risk reward ratio chartsJuly 2025 Macro Moves & AI Forecasted Stock Moves - newser.com
Custom strategy builders for tracking Evoke Pharma Inc.Market Volume Report & Real-Time Chart Breakout Alerts - newser.com
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):